home All News open_in_new Full Article

Bioherent consigue 2 millones para el diagnóstico de alergias

Axon Partners, el CDTI y Bullnet Capital participan en la operación de capital para que la compañía pueda seguir mejorando sus dispositivos médicos que diagnostican las alergias a los antibióticos. Leer


today 22 h. ago attach_file Politics

attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 3981419888
Add Watch Country

arrow_drop_down